KHEIRON Spinal Fixation System, including patient specific K-ROD
S.M.A.I.O · Decision date Sep 4, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-09-04 for K262828, a 510(k) premarket notification submitted by S.M.A.I.O of Saint-Priest, France, with BioVera, Inc. as correspondent. The device is the KHEIRON® Spinal Fixation System, including a patient specific K-ROD, classified as a Thoracolumbosacral Pedicle Screw System under 21 CFR 888.3070, product code NKB, with KWP listed as a subsequent product code. The application was received 08/10/2026, and the review panel and regulation medical specialty are both orthopedic.
SESE means the submission was cleared as substantially equivalent; it is not a PMA approval. The record shows a special summary, no third-party review, no combination product designation and no authorized predetermined change control plan. The public record does not state the predicate device, the specific design or material changes to the K-ROD, or any clinical performance data, so the basis for the equivalence finding and any patient-selection or use instructions remain in the FDA summary document rather than this listing.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Sep 4, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262828
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- S.M.A.I.O
- Product code
- NKB
- Decision code
- SESE
- Decision date
- Sep 4, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Thoracolumbosacral Pedicle Screw System.
FDA decision timeline
K262828 received
Application receipt date recorded by FDA.
K262828 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code NKB
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| SeaSpine Orthopedics Corporation | 510(k) clearance | Oct 29, 2026 | FDA | |
| GS Medical Co., Ltd. | 510(k) clearance | Oct 2, 2026 | FDA | |
NOVIX Pedicle Screw SystemK263062 | Tdm Co., Ltd. | 510(k) clearance | Oct 1, 2026 | FDA |
Duet Spinal Fixation SystemK262712 | Duet Spine Holdings, LLC | 510(k) clearance | Sep 30, 2026 | FDA |
| Spinal Alignment Solutions, Inc. | 510(k) clearance | Sep 30, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
S.M.A.I.O
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Saint-Priest
Sources and methodology
- Original FDA record: K262828
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


